4.8 Article

PATZ1 down-regulates FADS1 by binding to rs174557 and is opposed by SP1/SREBP1c

期刊

NUCLEIC ACIDS RESEARCH
卷 45, 期 5, 页码 2408-2422

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw1186

关键词

-

资金

  1. RFI/VR
  2. Science for Life Laboratory, Sweden
  3. Swedish Research Council [521-2010-3505, 6212011-6052, 521-2012-2884]
  4. Swedish Diabetes Foundation
  5. Diabetes Wellness Network Sweden
  6. Family Ernfors Fund
  7. Uppsala University
  8. EXODIAB
  9. Swedish Cancer Foundation [15 0878]

向作者/读者索取更多资源

The FADS1 and FADS2 genes in the FADS cluster encode the rate-limiting enzymes in the synthesis of long-chain polyunsaturated fatty acids (LC-PUFAs). Genetic variation in this region has been associated with a large number of diseases and traits many of them correlated to differences in metabolism of PUFAs. However, the causative variants leading to these associations have not been identified. Here we find that themultiallelic rs174557 located in anAluYe5 element in intron 1 of FADS1 is functional and lies within a PATZ1 binding site. The derived allele of rs174557, which is the common variant in most populations, diminishes binding of PATZ1, a transcription factor conferring allele-specific downregulation of FADS1. The PATZ1 binding site overlaps with a SP1 site. The competitive binding between the suppressive PATZ1 and the activating complex of SP1 and SREBP1c determines the enhancer activity of this region, which regulates expression

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Genetic Landscape of the ACE2 Coronavirus Receptor

Zhijian Yang, Erin Macdonald-Dunlop, Jiantao Chen, Ranran Zhai, Ting Li, Anne Richmond, Lucija Klaric, Nicola Pirastu, Zheng Ning, Chenqing Zheng, Yipeng Wang, Tingting Huang, Yazhou He, Huiming Guo, Kejun Ying, Stefan Gustafsson, Bram Prins, Anna Ramisch, Emmanouil T. Dermitzakis, Grace Png, Niclas Eriksson, Jeffrey Haessler, Xiaowei Hu, Daniela Zanetti, Thibaud Boutin, Shih-Jen Hwang, Eleanor Wheeler, Maik Pietzner, Laura M. Raffield, Anette Kalnapenkis, James E. Peters, Ana Vinuela, Arthur Gilly, Solve Elmstahl, George Dedoussis, John R. Petrie, Ozren Polasek, Lasse Folkersen, Yan Chen, Chen Yao, Urmo Vosa, Erola Pairo-Castineira, Sara Clohisey, Andrew D. Bretherick, Konrad Rawlik, Tonu Esko, Stefan Enroth, Asa Johansson, Ulf Gyllensten, Claudia Langenberg, Daniel Levy, Caroline Hayward, Themistocles L. Assimes, Charles Kooperberg, Ani W. Manichaikul, Agneta Siegbahn, Lars Wallentin, Lars Lind, Eleftheria Zeggini, Jochen M. Schwenk, Adam S. Butterworth, Karl Michaelsson, Yudi Pawitan, Peter K. Joshi, J. Kenneth Baillie, Anders Malarstig, Alexander P. Reiner, James F. Wilson, Xia Shen

Summary: In this study, genetic correlations between plasma ACE2 levels and cardiovascular disease, COVID-19, and other related diseases were identified. Mendelian randomization analysis showed a causal effect of elevated ACE2 levels on COVID-19 severity, hospitalization, and infection. The study also revealed that ACE2 regulatory variants were enriched for DNA methylation sites in blood immune cells.

CIRCULATION (2022)

Article Multidisciplinary Sciences

Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability

Marcin Kierczak, Nima Rafati, Julia Hoglund, Hadrien Gourle, Valeria Lo Faro, Daniel Schmitz, Weronica E. Ek, Ulf Gyllensten, Stefan Enroth, Diana Ekman, Bjorn Nystedt, Torgny Karlsson, Asa Johansson

Summary: Despite the success of genome-wide association studies, the genetic contribution to complex traits remains unexplained. This study analyzed whole-genome sequencing data to evaluate the impact of rare genetic variants on plasma proteins. The findings suggest that rare variants have a limited contribution to heritability but may play a role in precision medicine applications.

NATURE COMMUNICATIONS (2022)

Article Oncology

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer

Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjorn Ost, Jon Ramsell, Matilda Aslin, Emma Ivansson, Marta Lomnytska, Maria Lycke, Tomas Axelsson, Ulrika Liljedahl, Jessica Nordlund, Per-Henrik Edqvist, Tobias Sjoblom, Mathias Uhlen, Karin Stalberg, Karin Sundfeldt, Mikael Aberg, Stefan Enroth

Summary: Ovarian cancer is the eighth most common cancer in women, but its survival rate is low. Current biomarkers for early detection of cancer lack sensitivity and specificity, and new biomarkers are needed. This study measured protein biomarkers and found that combinations of 4-7 proteins can accurately detect early- and late-stage ovarian cancer.

CANCERS (2022)

Article Oncology

Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas

Holger Weishaupt, Matko Cancer, Gabriela Rosen, Karl O. Holmberg, Susana Haggqvist, Ignas Bunikis, Yiwen Jiang, Smitha Sreedharan, Ulf Gyllensten, Oren J. Becher, Lene Uhrbom, Adam Ameur, Fredrik J. Swartling

Summary: This study demonstrates a novel approach to tagging glioma genes using retroviral integration sites. By using a high-throughput pipeline coupled to a tumor model system, the researchers were able to detect retroviral integration sites in malignant stem cell lines from glioma biopsies. The results identified genes that have been dysregulated in glioma and also discovered novel potential cancer-causing genes.

NEURO-ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions

Josefin Johansson, Sarah Lideus, Carina Frykholm, Cecilia Gunnarsson, Filip Mihalic, Sanna Gudmundsson, Sara Ekvall, Anna-Maja Molin, Mai Pham, Mauno Vihinen, Kristina Lagerstedt-Robinson, Ann Nordgren, Per Jemth, Adam Ameur, Goeran Anneren, Maria Wilbe, Marie-Louise Bondeson

Summary: This study reveals the genetic and molecular factors underlying Gustavson syndrome, and identifies a novel in-frame deletion in the RBMX gene associated with this syndrome, leading to disrupted RNA polymerase II transcription and potentially reduced SH3 binding. These findings provide new insights into the pathogenesis of RBMX-related intellectual disabilities.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Cell Biology

The long non-coding RNA LINC00707 interacts with Smad proteins to regulate TGFβ signaling and cancer cell invasion

Caroline Gelabert, Panagiotis Papoutsoglou, Irene Golan, Eric Ahlstrom, Adam Ameur, Carl-Henrik Heldin, Laia Caja, Aristidis Moustakas

Summary: This study demonstrates that LINC00707 interacts with Smad proteins, limiting the output of TGF beta signaling and suppressing cancer cell invasion.

CELL COMMUNICATION AND SIGNALING (2023)

Article Multidisciplinary Sciences

Transposable element insertions in 1000 Swedish individuals

Kristine Bilgrav Saether, Daniel Nilsson, Hakan Thonberg, Emma Tham, Adam Ameur, Jesper Eisfeldt, Anna Lindstrand

Summary: The majority of rare diseases are genetic, and despite advances in genomics-based investigations, a large percentage of patients remain undiagnosed. A significant contributing factor to this is the limited understanding of transposable elements (TE), which make up a substantial portion of the human genome. This study aims to bridge this knowledge gap by characterizing TE insertions in different populations and highlights the potential clinical implications in rare disease diagnostics.

PLOS ONE (2023)

Article Multidisciplinary Sciences

A novel quantitative targeted analysis of X-chromosome inactivation (XCI) using nanopore sequencing

Josefin Johansson, Sarah Lideus, Ida Hoijer, Adam Ameur, Sanna Gudmundsson, Goeran Anneren, Marie-Louise Bondeson, Maria Wilbe

Summary: Researchers developed a novel strategy called XCI-ONT, which combines amplification-free Cas9 enrichment and Oxford nanopore technologies sequencing, to investigate and accurately quantify X-chromosome inactivation (XCI). The XCI-ONT strategy was shown to be more useful and reliable than the PCR-based golden standard technique, and it provides a valuable tool for studying X-linked traits in clinical and research settings.

SCIENTIFIC REPORTS (2023)

Article Genetics & Heredity

Copy number variations and their effect on the plasma proteome

Daniel Schmitz, Zhiwei Li, Valeria Lo Faro, Mathias Rask-Andersen, Adam Ameur, Nima Rafati, Asa Johansson

Summary: This study characterized CNVs in a Swedish cohort using whole-genome sequencing and identified CNVs associated with plasma proteins. Validations were done using long-read sequencing. The findings provide insights into the structure and effects of common CNVs on the plasma proteome.

GENETICS (2023)

Article Genetics & Heredity

Complete Mitochondrial DNA Genome Variation in the Swedish Population

Kimberly Sturk-Andreaggi, Martin Bodner, Joseph D. Ring, Adam Ameur, Ulf Gyllensten, Walther Parson, Charla Marshall, Marie Allen

Summary: The study analyzed the mitochondrial DNA (mtDNA) reads from the SweGen whole genome sequencing dataset to characterize mitogenome variation in Sweden. A total of 934 forensic-quality mitogenome haplotypes were identified, with almost 45% belonging to haplogroup H. The majority (99.1%) of the mitogenome haplotypes were assigned to European haplogroups, as expected. The study also observed signature haplogroups from northern Sweden and Finland, consistent with previous nuclear DNA analyses. The complete mitogenome analysis showed high haplotype diversity and a low random match probability.
Article Genetics & Heredity

The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots

Gregory Lazarian, Bernard Leroy, Floriane Theves, Myriam Hormi, Remi Letestu, Virginie Eclache, Giulia Tueur, Adam Ameur, Audrey Bidet, Pascale Cornillet-Lefebvre, Frederic Davi, Eric Delabesse, Marie-Helene Estienne, Pascaline Etancelin, Olivier Kosmider, Sophy Laibe, Marc Muller, Nathalie Nadal, Dina Naguib, Cedric Pastoret, Stephanie Poulain, Pierre Sujobert, Lauren Veronese, Samia Imache, Valerie Lefebvre, Florence Cymbalista, Fanny Baran-Marszak, Thierry Soussi

Summary: TP53 aberrations are a major predictive factor for resistance to chemoimmunotherapy in CLL. This study analyzed 1,056 TP53 variants from 683 patients in France and compared them to a dataset of 5,173 TP53 variants from published articles. The analysis identified CLL-specific hotspot mutations and a novel splice variant. The study also found frequent copy-neutral loss of heterozygosity in CLL and the presence of multiple TP53 variants in a high proportion of patients.

HUMAN MUTATION (2023)

Meeting Abstract Biochemistry & Molecular Biology

Novel in-frame deletion in RBMX leads to X-linked intellectual disability by disturbed RNA processing, splicing regulation and potentially reduced SH3 binding

Josefin Johansson, Sarah Lideus, Filip Mihalic, Mauno Vihinen, Carina Frykholm, Sanna Gudmundsson, Adam Ameur, Per Jemth, Marie-Louise Bondeson, Maria Wilbe

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Meeting Abstract Biochemistry & Molecular Biology

A polygenic risk score predicts mosaic loss of chromosome Y in circulating blood cells

Jonas Mattisson, Moeen Riaz, Galina Polekhina, Andrew Bakshi, Jonatan Halvardson, Marcus Danielsson, Adam Ameur, John McNeil, Lars Forsberg, Paul Lacaze

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Oncology

Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening

Wesley Schaal, Adam Ameur, Ulla Olsson-Stromberg, Monica Hermanson, Lucia Cavelier, Ola Spjuth

Summary: This project aimed to implement long-read sequencing for screening TKI resistance mutations in patients with chronic myeloid leukemia, successfully establishing automated analysis processes and an information system for better sensitivity and early detection of emerging mutations.

CANCER INFORMATICS (2022)

Article Medicine, Research & Experimental

Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment

Stefan Enroth, Emma Ivansson, Julia Hedlund Lindberg, Maria Lycke, Jessica Bergman, Anna Reneland, Karin Stalberg, Karin Sundfeldt, Ulf Gyllensten

Summary: This study developed a risk score based on an 11-protein plasma assay to distinguish between benign and malignant ovarian tumors. The assay showed robust performance in diagnostic work-up and predicting clinical course.

COMMUNICATIONS MEDICINE (2022)

暂无数据